Amgen Drug Slows Spread of Cancer but Doesn’t Extend Life
Amgen shares jumped 6% in late trading on word that a study of its bone drug Xgeva showed that the drug, which is already FDA approved to help patients who…
Today News
Amgen shares jumped 6% in late trading on word that a study of its bone drug Xgeva showed that the drug, which is already FDA approved to help patients who…